Affiliation:
1. Department of Dermatology Oregon Health & Science University Portland Oregon USA
2. Dermatopathology and Oral Pathology Service, Department of Pathology University of California San Francisco San Francisco California USA
3. Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health Rockville Maryland USA
4. Laboratory of Pathology, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA
Abstract
AbstractA host of signature genetic alterations have been demonstrated in Spitz neoplasms, most notably fusions of kinase genes (including BRAF, ALK, ROS1, NTRK1, NTRK3, RET, MET, MAP3K8) or variants in HRAS. While there are multiple reports of rearrangements involving NTRK1 and NTRK3 in Spitz tumors, there are very few reports of NTRK2‐rearranged Spitz nevi in the literature. This report presents an NTRK2‐rearranged atypical Spitz tumor with spindled cell features. The patient was a 6‐year‐old female with a growing pigmented papule on the back. Histopathological evaluation revealed an asymmetric, biphasic, compound proliferation of melanocytes featuring an epithelioid cell population arranged as variably sized nests and single cells along the basal layer with extension down adnexa, as well as a population of spindled melanocytes with desmoplastic features and loss of Melan‐A expression in the dermis. There was partial loss of p16 expression in the epidermal component and diffuse loss in the dermal component. Immunohistochemistry for PRAME, ALK, NTRK1, HRAS Q61R, p53, and BRAF V600E were negative. A SQSTM1::NTRK2 fusion was identified by RNA sequencing. No TERT promoter hotspot variants were detected. This case report expands the known histopathologic spectrum of genetic alterations in Spitz neoplasms.
Funder
National Cancer Institute Division of Cancer Epidemiology and Genetics
Center for Cancer Research
Subject
Dermatology,Histology,Pathology and Forensic Medicine